ArticleInvestigational new drugs2021

The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathway.

Linping Lei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.